Home » Topics » BioWorld Science

BioWorld Science
RSS

Locus Biosciences completes phase Ib study of LBP-EC01 bacteriophage therapy

Feb. 25, 2021

Insilico Medicine announces preclinical candidate for IPF

Feb. 25, 2021

Bacterial protease takes on "undruggable" oncoprotein

Feb. 25, 2021

Generex reports data on Ii-Key-SARS-CoV-2 vaccine in transgenic mouse model

Feb. 25, 2021

Decibel Therapeutics presents DB-OTO for genetic hearing loss

Feb. 25, 2021

New model developed for testing drugs for Nav1.9-related neuropathic pain

Feb. 25, 2021

Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype

Feb. 25, 2021

Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel

Feb. 25, 2021

Benitec reports interim data on pilot dosing study of BB-301 for OPMD

Feb. 25, 2021

Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome

Feb. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026